Nephroprotective Effects of Tanacetum balsamita Extract on Metabolic-Induced Renal Injury (MIRI) in Rats
Rumyana Simeonova, Reneta Gevrenova, Lyubomir Marinov, Yonko Savov, Dimitrina Zheleva-Dimitrova

TL;DR
This study shows that Tanacetum balsamita extract can protect rat kidneys from diabetes-related damage by reducing oxidative stress and improving kidney function.
Contribution
The novel contribution is the identification of Tanacetum balsamita extract's nephroprotective effects in a rat model of metabolic-induced renal injury.
Findings
High-dose Tanacetum balsamita extract significantly reduced blood glucose and improved antioxidant markers in diabetic rats.
The extract lowered urea and creatinine levels and reduced proteinuria, indicating improved kidney function.
Histopathological analysis confirmed protective effects of the extract on kidney tissue.
Abstract
The progression of type 2 diabetes is associated with multiple complications, one of which is diabetic nephropathy (DN). This study aimed at investigating the nephroprotective potential of two doses 150 mg/kg and 300 mg/kg of Tanacetum balsamita leaf extract (ETB) on metabolic-induced renal injury (MIRI) in rats. Markers of renal oxidative stress and antioxidant defense, histopathology, serum biochemistry, and urinalysis were measured. Blood glucose level and arterial blood pressure were assessed weekly for the experimental period of eight weeks. ETB at a high dose significantly decreased the blood glucose levels and mildly lowered systolic pressure in diabetic rats. In the kidney, ETB restored the antioxidant marker malondialdehyde, reduced glutathione, and markedly increased enzymatic activity related to GSH turnover by 46% (GPx), 22% (GR), 32% (GST), and 96% (SOD). ETB reduced…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsChronic Kidney Disease and Diabetes · Natural Antidiabetic Agents Studies · Eicosanoids and Hypertension Pharmacology
